Dr. Danso is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5900 Lake Wright Dr
Norfolk, VA 23502Phone+1 757-466-8683Fax+1 757-466-8892
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2002
Royal Free Hospital and University College London Medical SchoolClass of 1996
Certifications & Licensure
VA State Medical License 2007 - 2024
FL State Medical License 2005 - 2017
NY State Medical License 2002 - 2007
PA State Medical License 2000 - 2002- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations Start of enrollment: 2010 Feb 01
- Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women Start of enrollment: 2014 Mar 11
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- 207 citationsPhase III Study of Iniparib Plus Gemcitabine and Carboplatin Versus Gemcitabine and Carboplatin in Patients With Metastatic Triple-Negative Breast CancerJoyce O'Shaughnessy, Lee S. Schwartzberg, Michael A. Danso, Kathy D. Miller, Hope S. Rugo
Journal of Clinical Oncology. 2014-10-27 - 431 citationsAn estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgenAshley S. Doane, Michael A. Danso, Priti Lal, M. Donaton, Liying Zhang
Oncogene. 2006-06-29 - 47 citationsThe prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practiceNatalie B. Simon, Michael A. Danso, Thomas Alberico, Ethan Basch, Antonia V. Bennett
Quality of Life Research. 2017-06-29
Press Mentions
GHS Sets up Committee to Investigate Death of Supposed Covid-19 PatientAugust 21st, 2021
Panic as Effia Nkwanta Hospital Runs of Out BloodApril 25th, 2020
Abura Dunkwa District Hospital Cries for DoctorsApril 17th, 2019
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
